当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 利润表

尔康制药

(300267)

  

流通市值:39.54亿  总市值:57.34亿
流通股本:14.22亿   总股本:20.63亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入1,445,366,591.951,050,160,519.66546,925,468.791,870,540,810.78
营业收入1,445,366,591.951,050,160,519.66546,925,468.791,870,540,810.78
二、营业总成本1,458,628,102.51,034,277,548.73525,219,144.991,882,005,367.94
营业成本1,091,509,235785,439,197.64423,002,313.271,454,904,548.74
税金及附加14,376,049.9810,452,618.613,480,579.2611,991,149.85
销售费用89,431,493.9467,516,427.1322,273,468.53112,238,876.53
管理费用219,006,548.39143,818,980.7964,022,936.18241,513,937.98
研发费用40,831,111.2122,996,806.78,289,742.8448,146,348.68
财务费用3,473,663.984,053,517.864,150,104.9113,210,506.16
其中:利息费用5,526,089.44,566,670.593,139,189.835,502,001.01
其中:利息收入3,203,878.361,487,685.54644,768.172,466,288.13
加:公允价值变动收益-14,116,727.53-4,439,278.8-13,138,571.6514,116,727.53
加:投资收益18,988,223.75-87,797.04-806,286.514,699,321.46
资产处置收益12,606,669.7112,339,140.25-53,235.61
资产减值损失(新)316,661.18513,792.22627,336.17-4,844,502.49
信用减值损失(新)9,558,791.169,639,536.635,095,018.69-6,728,027.85
其他收益21,724,247.7814,747,560.745,434,002.1417,947,717.14
营业利润平衡项目0000
四、营业利润35,816,355.548,595,924.9318,917,822.6413,779,914.24
加:营业外收入5,896,757.125,328,701.084,170,401.195,262,878.72
减:营业外支出406,697.87258,229.092,226,234.671,688,598.58
利润总额平衡项目0000
五、利润总额41,306,414.7553,666,396.9220,861,989.1617,354,194.38
减:所得税费用17,344,103.412,547,685.12406,495-19,536,608.67
六、净利润23,962,311.3541,118,711.820,455,494.1636,890,803.05
持续经营净利润23,962,311.3541,118,711.820,455,494.1636,890,803.05
归属于母公司股东的净利润40,074,092.4451,950,756.0826,078,945.6345,757,944.56
少数股东损益-16,111,781.09-10,832,044.28-5,623,451.47-8,867,141.51
(一)基本每股收益0.020.030.010.02
(二)稀释每股收益0.020.030.010.02
八、其他综合收益53,865,324.8664,227,558.01-22,816,079.17149,215,469.71
归属于母公司股东的其他综合收益53,493,978.3163,764,569.79-22,581,727.09147,884,159.41
九、综合收益总额77,827,636.21105,346,269.81-2,360,585.01186,106,272.76
归属于母公司股东的综合收益总额93,568,070.75115,715,325.873,497,218.54193,642,103.97
归属于少数股东的综合收益总额-15,740,434.54-10,369,056.06-5,857,803.55-7,535,831.21
公告日期2023-10-232023-08-282023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑